Chip Design Sector Draws Investor Interest as AI and Edge Computing Fuel Demand Popular BPOP Q1 2026 Earnings Beat Revenue NA EPS 378 Syngenta Launches VoiceEnabled AI Chatbot to Support Farmers Oragenics OGEN Q2 2023 Beat Revenue NA EPS Exceeds by Significant Duke Energy DUK Faces Reduced Analyst Price Target Amid Utility Sector Headwinds AnheuserBusch InBev Shares Dip on Revenue Miss BofA Analyst Raises Philip Morris International Price Target Signaling Confidence in SmokeFree Strategy Scotiabank Updates Price Target for Welltower WELL Amid Positive Outlook VTI vs SPY Wall Streets Laziest Fund Outpaces the SP 500 Should Investors Pay Attention Nostalgia and Speculation Drive Millions in Pokmon Card Market RITM Q1 2026 Earnings Modest EPS Beat Highlights Stability in Mortgage Real Estate UCL Q1 2026 Earnings EPS Beat Highlights Operational Efficiency Amid Revenue Discrepancy USCB Q1 2026 Earnings Earnings Beat Driven by Strong Net Interest Margin NATH Q4 2024 Earnings EPS of 096 Reported Amid Modest Stock Reaction AGNCO Q1 2026 Earnings Preferred Dividend Surpasses Expectations as FixedtoFloating Rate Benefits NTWK Q1 2026 Earnings Positive Profitability Trends Amid Transformational Growth iOThree Limited IOTR Declines 385 as Stock Tests Key Support at 19 Corbus Pharmaceuticals CRBP Under Pressure at 782 Key Support and Resistance in Focus First Merchants Corporation FRME Slips Key Support Levels Tested After 115 Decline Rumble Inc Warrant RUMBW Surges 158 as Momentum Builds Above Key Support Gyre Therapeutics Inc GYRE Edges Lower Testing Key Support Levels Indian Markets Edge Higher Financials Lead While Pharma Caps Gains Key Levels on Watch SOHU Q1 2026 Earnings EPS of 016 Reported Shares Dip 077 Amid Limited Disclosure El Pollo Loco Holdings LOCO Holds Steady Near Key Support Amid Quiet Trading Novo Nordisk AS NVO Q1 2026 Earnings Strong EPS Beat Driven by Obesity and Diabetes Portfolio DaVita Q1 2026 Earnings EPS Surges Past Estimates by 226 Yet Stock Barely Moves TECX Q1 2026 Earnings WiderthanExpected Loss Amidst PreRevenue Stage Dianthus Therapeutics Q1 2026 Earnings EPS Beat Amid PreRevenue Stage Erasca Inc ERAS Q1 2026 Earnings WiderThanExpected Loss Weighs on Shares OGEN Q2 2023 Earnings NarrowerthanExpected Loss Boosts Investor Sentiment EFXT Q1 2026 Earnings Earnings Surge Past Estimates by 65